MRI Assessment of Aβ-Iron Interaction in PS/APP Mouse Brain
Principal Investigator
Maria Falangola, MD, PhD
The Research Foundation for Mental Hygiene
Menands, NY, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
A2005204
Summary
Dr. Falangola has been investigating the association between iron and changes in magnetic resonance imaging (MRI) parameters in humans and animals. She believes that the presence of iron in Aβ plaques is responsible for reducing transverse relaxation time (T2), and the source of the plaque intrinsic MRI contrast seen in tested animals. The overall goal of Dr. Falangola’s research is to utilize a transgenic mouse model of Aβ deposition to establish the relationship between Aβ-iron complex and its influence on MRI parameters. Knowledge of the underlying mechanisms of the influence of Aβ accumulation on quantitative MRI parameters could provide the ability to non-invasively quantify the degree of plaque burden.
Grants
Related Grants
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Alzheimer's Disease Research
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Identifying Women-Specific and Men-Specific Risk Factors for Alzheimer’s Disease
Active Dates
July 01, 2022 - June 30, 2024
Principal Investigator
Gael Chetelat, PhD
Alzheimer's Disease Research
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD
Mitochondrial Prodrug to Treat Repeated Mild Traumatic Brain Injury
Active Dates
September 08, 2021 - December 31, 2023
Principal Investigator
Patrick Sullivan, PhD